4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0000950170-24-081607
Options or other derivatives
- Director acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mulroy Michael H. Director | 2024-07-01 | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…